HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 194 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $65,000 | +14.0% | 3,672 | -3.6% | 0.00% | – |
| Q3 2019 | $57,000 | -16.2% | 3,808 | -3.1% | 0.00% | -100.0% |
| Q2 2019 | $68,000 | +9.7% | 3,929 | +0.9% | 0.00% | 0.0% |
| Q1 2019 | $62,000 | -3.1% | 3,895 | -10.9% | 0.00% | 0.0% |
| Q4 2018 | $64,000 | -22.0% | 4,373 | -2.5% | 0.00% | 0.0% |
| Q3 2018 | $82,000 | +57.7% | 4,484 | +48.0% | 0.00% | 0.0% |
| Q2 2018 | $52,000 | -17.5% | 3,029 | -4.8% | 0.00% | 0.0% |
| Q1 2018 | $63,000 | +28.6% | 3,181 | +30.9% | 0.00% | 0.0% |
| Q4 2017 | $49,000 | +69.0% | 2,430 | +40.5% | 0.00% | – |
| Q3 2017 | $29,000 | +38.1% | 1,730 | +3.4% | 0.00% | – |
| Q2 2017 | $21,000 | +10.5% | 1,673 | +15.9% | 0.00% | – |
| Q1 2017 | $19,000 | +90.0% | 1,444 | +36.0% | 0.00% | – |
| Q4 2016 | $10,000 | -73.0% | 1,062 | -65.3% | 0.00% | -100.0% |
| Q3 2016 | $37,000 | +42.3% | 3,062 | -0.0% | 0.00% | 0.0% |
| Q2 2016 | $26,000 | – | 3,063 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |